Status:

TERMINATED

Hysteroscopic Lymphatic Mapping for Endometrial Cancer

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Endometrial Cancer

Eligibility:

FEMALE

Phase:

PHASE2

Brief Summary

The goal of this clinical research study is to learn if a procedure called intraoperative (during surgery) lymphatic mapping can be used to find the sentinel lymph node in patients with endometrial ca...

Detailed Description

Experimental Procedures: Lymph nodes are oval-shaped glands where immune reactions occur. For patients with endometrial cancer, lymph node status is an important factor for planning the cancer treatm...

Eligibility Criteria

Inclusion

  • Patients with biopsy confirmed endometrial cancer who have been dispositioned to undergo total hysterectomy, bilateral salpingooophorectomy and lymph node staging.
  • Surgical procedures may be performed by either laparotomy or laparoscopy.
  • If computed tomography, magnetic resonance imaging, lymphangiography, or ultrasound has been performed for preoperative assessment, there must be no evidence of metastases. Imaging is not mandatory.
  • Patients who have signed an approved informed consent and authorization permitting release of personal health information.

Exclusion

  • Patients with a preoperative diagnosis of grade I endometrioid adenocarcinoma of the uterus.
  • Patients with uterine papillary serous carcinoma.
  • Patients who have undergone endometrial ablation or a myomectomy within 1 year of the surgery for endometrial cancer.
  • Patients with known allergies to triphenylmethane compounds or technetium-99 radiocolloid.
  • Patients with a history of retroperitoneal surgery.
  • Patients with a history of pelvic radiation.
  • Patients with no lesion visible on hysteroscopy.
  • Patients with previous exposure to the tracer (to prevent risk of allergic reaction).

Key Trial Info

Start Date :

April 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT00671606

Start Date

April 1 2008

End Date

June 1 2010

Last Update

May 27 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

St. Luke's Episcopal Hospital

Houston, Texas, United States, 77030

2

UT MD Anderson Cancer Center

Houston, Texas, United States, 77030